Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex, Inc.

39.93
-0.2650-0.66%
Volume:295.20K
Turnover:11.71M
Market Cap:6.32B
PE:-117.60
High:40.16
Open:39.89
Low:39.14
Close:40.19
Loading ...

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire
·
07 Mar

Vertex Pharmaceuticals' Triple Combination Cystic Fibrosis Therapy Alyftrek Receives Approval in UK

MT Newswires Live
·
07 Mar

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
07 Mar

3 Stocks Estimated To Be Up To 49.3% Below Their Intrinsic Value

Simply Wall St.
·
07 Mar

Vertex non-opioid pain drug picked up by UnitedHealth

TIPRANKS
·
07 Mar

Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary

MT Newswires Live
·
07 Mar

Bernstein Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
06 Mar

Vertex Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
06 Mar

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

GlobeNewswire
·
06 Mar

TD Cowen Remains a Buy on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
05 Mar

Vertex Pharmaceuticals Leads 3 Value Stocks Offering Estimated Intrinsic Value

Simply Wall St.
·
05 Mar

Vertex Pharmaceuticals: Buy Rating Driven by Outpatient Market Potential and Strategic Initiatives for Journavx

TIPRANKS
·
05 Mar

Top Executive Makes Bold Move with Major Vertex Stock Purchase!

TIPRANKS
·
05 Mar

5 Top Stocks to Buy in March

Motley Fool
·
04 Mar

Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market

TIPRANKS
·
04 Mar

Vertex Is Maintained at Buy by Goldman Sachs

Dow Jones
·
03 Mar

Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians

GlobeNewswire
·
03 Mar

Vertex, Inc. (VERX): Among the Worst Performing Software Stocks to Buy According to Analysts

Insider Monkey
·
03 Mar

Vertex, Inc. Faces Financial Turmoil Amid Potential ‘Fundamental Change’ Risks

TIPRANKS
·
01 Mar

Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
01 Mar